Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06733584 · ClinicalTrials.gov registry record · NA

Meeting the Needs of Young Hispanic Autistic Children

A NA study of Autism, sponsored by The University of Texas at Dallas.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
3
Study locations

NCT06733584: Recruiting NA study of Autism, sponsored by The University of Texas at Dallas.

NCT06733584 is a NA study of Autism that is actively recruiting participants, run by The University of Texas at Dallas. The registered enrollment target is 200 participants, above the 181-participant average among 104 other Autism trials with a reported enrollment target (10% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06733584, a NA study of Autism, is actively recruiting participants, sponsored by The University of Texas at Dallas.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
3
Study locations

Study Summary

Purpose of the Study: The goal of this clinical trial is to find out if a technique called the "mutual gaze procedure" used in a Culturally and Linguistically Responsive adaptation of Pathways Early Intervention (CLR-Pathways) is the key to improving social communication, language, and everyday skills in young (18-42 months) Hispanic autistic children experiencing low income. What Will Happen: Researchers will compare two versions of CLR-Pathways. * Version 1: Includes mutual gaze strategies. * Version 2: Does not include mutual gaze strategies. What to Expect: Participants will: * Attend 16 sessions (or 18 weeks if there are cancellations) of Pathways Intervention, each lasting 1.5 hours. * Come to the clinic for a developmental check-up three times: before starting Pathways, right after completing Pathways, and three months after finishing Pathways.

Primary Outcome

Two dyadic measures of respeto will be coded using two items from the Joint Engagement Rating Inventory (JERI; Adamson et al., 2020). The Parent Calm Authority (PCA) subscale will measure the extent to which a parent influences the interaction using an assertive and confident yet gentle approach. The Child Affiliative Obedience (CAO) subscale will capture the child's affiliation, deference, and amenability to the parent's direction. These are scored using 7-point Likert scales (where 1 indicates

Conditions Studied

Interventions

  • BEHAVIORAL Culturally and Linguistically Responsive Pathways Parent-Mediated Intervention without Mutual Gaze
  • BEHAVIORAL Culturally and Linguistically Responsive Pathways Parent-Mediated Intervention

Study Locations (3)

Texas

  • Catholic Charities of Dallas - Dallas
  • University of Texas at Dallas - Richardson

Kansas

  • University of Kansas - Lawrence

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-09-22
Est. Completion 2028-01
Phase NA
The University of Texas at Dallas

50 total trials

What NCT06733584 shows while recruiting

NCT06733584 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 181-participant average among 104 other Autism trials with a reported enrollment target (10% higher).

The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 2 interventions - of which Culturally and Linguistically Responsive Pathways Parent-Mediated Intervention without Mutual Gaze is the first listed.

NCT06733584 reports a single indexed study location in Texas, Kansas.

Frequently Asked Questions

What is clinical trial NCT06733584 about?

NCT06733584 is a clinical study titled "Meeting the Needs of Young Hispanic Autistic Children". Purpose of the Study: The goal of this clinical trial is to find out if a technique called the "mutual gaze procedure" used in a Culturally and Linguistically Responsive adaptation of Pathways Early Intervention (CLR-Pathways) is the key to improving social communication, language, and everyday skil...

What is the current status of trial NCT06733584?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-09-22. Estimated completion is 2028-01.

What conditions does trial NCT06733584 study?

This clinical trial studies the following conditions: Autism.

What interventions are being tested in trial NCT06733584?

The interventions under investigation include: Culturally and Linguistically Responsive Pathways Parent-Mediated Intervention without Mutual Gaze (BEHAVIORAL), Culturally and Linguistically Responsive Pathways Parent-Mediated Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06733584?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06733584 being conducted?

This trial has 3 study locations across Kansas, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06733584's enrollment target sits among peer trials

200 20th of 104 higher than 84 of 104 other Autism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06733584, the US trial registry maintained by the National Library of Medicine. NCT06733584 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.